Zevra Therapeutics, Inc. ZVRA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s operating income?
- Zevra Therapeutics, Inc. (ZVRA) reported operating income of $52.15M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s operating income changed year-over-year?
- Zevra Therapeutics, Inc.'s operating income increased by 1072.5% year-over-year, from -$5.36M to $52.15M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating income?
- Over 2 years (2022 to 2024), Zevra Therapeutics, Inc.'s operating income has grown at a 43.0% compound annual growth rate (CAGR), from -$42.57M to -$87M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.